These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21735664)

  • 1. [Application of botulinum toxin A in chronic intrinsic rhinitis].
    Nowak K; Szyfter W
    Otolaryngol Pol; 2011; 65(2):103-5. PubMed ID: 21735664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive application of botulinum toxin type A in nasal hypersecretion.
    Rohrbach S; Laskawi R
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(6):382-4. PubMed ID: 11713429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum Toxin for Rhinitis.
    Ozcan C; Ismi O
    Curr Allergy Asthma Rep; 2016 Aug; 16(8):58. PubMed ID: 27461136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botolinum toxin in rhinitis: Literature review and posterior nasal injection in allergic rhinitis.
    Zhang EZ; Tan S; Loh I
    Laryngoscope; 2017 Nov; 127(11):2447-2454. PubMed ID: 28681969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis.
    Ozcan C; Vayisoglu Y; Doğu O; Görür K
    Am J Otolaryngol; 2006; 27(5):314-8. PubMed ID: 16935174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the effects of intranasal botulinum toxin type A and ipratropium bromide nasal spray on nasal hypersecretion in idiopathic rhinitis without eosinophilia.
    Sapci T; Yazici S; Evcimik MF; Bozkurt Z; Karavus A; Ugurlu B; Ozkurt E
    Rhinology; 2008 Mar; 46(1):45-51. PubMed ID: 18444492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis.
    Rohrbach S; Junghans K; Köhler S; Laskawi R
    Head Face Med; 2009 Oct; 5():18. PubMed ID: 19835591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study.
    Braun T; Gürkov R; Kramer MF; Krause E
    Am J Otolaryngol; 2012; 33(1):64-7. PubMed ID: 21419514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of botulinum toxin type A injection for intrinsic rhinitis.
    Kim KS; Kim SS; Yoon JH; Han JW
    J Laryngol Otol; 1998 Mar; 112(3):248-51. PubMed ID: 9624373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of botulinum toxin type A on vasomotor rhinitis and morphological study].
    Wang J; Chen F; Meng M; Zhang X; Chen Y; Huang W; Wang Y
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Nov; 17(11):643-5. PubMed ID: 14971193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two different formulations of botulinum toxin A for the treatment of blepharospasm and hemifacial spasm.
    Wu CJ; Shen JH; Chen Y; Lian YJ
    Turk Neurosurg; 2011; 21(4):625-9. PubMed ID: 22194126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A series of three sequential, randomized, controlled studies of repeated treatments with botulinum toxin type A for migraine prophylaxis.
    Elkind AH; O'Carroll P; Blumenfeld A; DeGryse R; Dimitrova R;
    J Pain; 2006 Oct; 7(10):688-96. PubMed ID: 17018329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin A and B: a comparative dosing study for spasmodic dysphonia.
    Blitzer A
    Otolaryngol Head Neck Surg; 2005 Dec; 133(6):836-8. PubMed ID: 16360499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum A toxin (BOTOX) in different types of facial dystonia.
    Shoaib KK; Inam-ul-Haq ; Khan MD
    J Coll Physicians Surg Pak; 2009 Nov; 19(11):742-3. PubMed ID: 19889277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
    Díaz-Llopis IV; Gómez-Gallego D; Mondéjar-Gómez FJ; López-García A; Climent-Barberá JM; Rodríguez-Ruiz CM
    Clin Rehabil; 2013 Aug; 27(8):681-5. PubMed ID: 23411793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of efficacy increases with the repetition of botulinum toxin A injections in primary axillary hyperhidrosis: a study in 83 patients.
    Lecouflet M; Leux C; Fenot M; Célerier P; Maillard H
    J Am Acad Dermatol; 2013 Dec; 69(6):960-4. PubMed ID: 24035554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial.
    Unal M; Sevim S; Doğu O; Vayisoğlu Y; Kanik A
    Acta Otolaryngol; 2003 Dec; 123(9):1060-3. PubMed ID: 14710908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the VHI, VHI-10, and V-RQOL for measuring the effect of botox therapy in adductor spasmodic dysphonia.
    Morzaria S; Damrose EJ
    J Voice; 2012 May; 26(3):378-80. PubMed ID: 20951552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.